🇺🇸 FDA

Company profile · Sponsor

AEON

AEON Biopharma

AEON · NYSE biotech IRVINE, CA, USA
Pipeline
9
Drugs
0
Patents
8

Quick answer

AEON (AEON) is a biotech company. headquartered in IRVINE, CA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker AEON
Exchange NYSE
Company type biotech
Headquarters IRVINE, CA, USA
SEC CIK 0001837607

Pipeline (9)

Search pipeline →

  1. ABP-450

    AEON

    Cervical Dystonia

    phase 2 small molecule completed

    2 trials

  2. ABP-450

    AEON

    Migraine

    phase 2 small molecule terminated

    2 trials

  3. Mitomycin C

    AEON

    Glaucoma

    phase 2 small molecule completed

    1 trial

  4. Provisc

    AEON

    Steroid Induced Glaucoma

    phase 2 small molecule completed

    1 trial

  5. ET1402L1-ARTEMIS™ T cells -IV

    AEON

    Hepatocellular Carcinoma

    phase 1 mab completed

    1 trial

  6. Ologen Collagen Matrix

    AEON

    Congenital Glaucoma

    phase 1 other active

    1 trial

  7. autologous ET1402L1-CART cells

    AEON

    Hepatocellular Carcinoma

    phase 1 mab terminated

    1 trial

  8. Use of Mitomycin-C (MMC) in trabeculectomy

    AEON

    Glaucoma

    approved small molecule completed

    1 trial

  9. Use of Mitomycin-C in trabeculectomy

    AEON

    Open-angle Glaucoma

    small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 11911455

    HPV therapeutic nucleic acid vaccine

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11826405

    Neurotoxin compositions for use in treating headache

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9901606

    Euglena lysate composition

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9274109

    Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

    Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9201072

    Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9149542

    Microvesicles derived from cell protoplast and use thereof

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9084830

    Microvesicles derived from cell protoplast and use thereof

    Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8969653

    Extracellular vesicles derived from gram-positive bacteria, and use thereof

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is AEON?

AEON (AEON) is a biotech company. headquartered in IRVINE, CA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does AEON sponsor?

We track 9 ClinicalTrials.gov-linked programs for AEON, including ABP-450 and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does AEON company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.